Researchers found that neural crest stem cells are uniquely capable of reprogramming, challenging current reprogramming ...

The field of engineered cell ... of cell therapy and immunology, we welcome articles addressing, but not limited to, the following themes: - Construction of CAR or other engineered T cell receptors - ...

UC San Francisco treated its first brain cancer patient with an experimental new CAR-T therapy discovered and manufactured at ...

Researchers from the Center for Regenerative Medicine (CReM) and the Department of Medicine at Boston Medical Center (BMC) ...

Cell and gene therapy companies are the beneficiaries of positive changes along the regulatory path that the U.S. FDA is paving for them, according to a panel of executives who spoke at the BioFuture ...

CRISPR/Cas9 is a gene editing tool that has revolutionized biomedical research and led to the first FDA-approved CRISPR-based gene therapy.

In Usher syndrome, genetic mutations cause both hearing and vision loss. Cell biologist Professor Uwe Wolfrum from Mainz University is researching the molecular background of this rare genetic ...

Using state-of-the-art technology, researchers have identified several specific steps needed for CRISPR to become active and perform its gene editing function. These preclinical findings could lead to ...

Former President Trump and Sen. JD Vance's cell phones were targeted in a Chinese hacking campaign, sources tell NBC News. Another source said people involved with the campaign of Vice President ...

JCR Pharmaceuticals presented promising preclinical data on their innovative gene therapy approach using J-Brain Cargo technology at a recent congress. This technology shows potential in treating ...

which stabilizes muscle cell membranes and supports the contractile apparatus. Without dystrophin, muscle becomes fragile and easily degenerates. A new single-dose intravenous gene therapy, ...

These developments could significantly enhance therapeutic applications, offering promising new avenues for gene therapy in hematopoietic stem and progenitor cells. Investors may find these ...